Clinical use of prostaglandins for pregnancy termination.
D000028:Abortion, Induced; D000650:Amnion; D004341:Drug Evaluation; D047108:Embryonic Development; D005260:Female; D006801:Humans; D007267:Injections; D007273:Injections, Intramuscular; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011458:Prostaglandins E / Q000627:therapeutic use; D011460:Prostaglandins F / Q000627:therapeutic use; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use; D013488:Suppositories; D014599:Uterus; D014621:Vagina
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D012462:Saline Solution, Hypertonic; D013488:Suppositories